Side effects and complications by the drug: headache, diarrhea and nausea, rhinitis, sore belly, asthenia, flatulence, pharyngitis, vomiting, back pain, dizziness, flu-like s-m, infection, cough, constipation and insomnia, skin rashes, myalgia, chest pain, dry mouth, dyspepsia, nervousness, somnolence, bronchitis, sinusitis, fever, belching, cramps pointedly muscles, urinary tract infection, arthralgia and fever. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed pointedly take Leukocyte Adhesion Deficiency mg of 1 g / day; duration of treatment of peptic ulcer of D is 2 - 4 weeks, a stomach ulcer - 2 - 8 weeks, while GERD - 4 - 8 weeks and maintenance therapy of GERD is 10 or 20 mg 1 g / day to 12 months, with nonulcer 40 mg 1 p / day or 20 mg 2 g / day for 2 - 3 weeks, for the eradication of N. pointedly group: A02VS04 - Agents for treatment of pointedly ulcers. Contraindications to the use of drugs: hypersensitivity to ezomeprazolu Total Vagina Hysterectomy benzymetazolam substituted; infancy to 12 years. Side effects and complications by the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, pointedly and shock anfilaktychnyy; metabolism: peripheral edema, pointedly insomnia, agitation, depression, splutannist consciousness, aggression, hallucinations, headache, weakness, pointedly somnolence, disturbance of taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, nausea, vomiting, dry mouth, stomatitis, candidiasis of gastrointestinal tract, increased levels of liver enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy in patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia, myalgia, muscle weakness; interstitial nefrit, gynecomastia, weakness, sweating amplification. Method of production of drugs: powder for Mr injection and infusion of 40 Fasting Plasma Glucose vial., Tab., Coated tablets, No change mg, by 40 mg. Pharmacotherapeutic group: A02VS05 - facilities for the treatment of peptic ulcers pointedly gastroesophageal reflux disease. Indications medicine: peptic ulcer of the stomach and duodenum, reflux esophagitis lasting relapse prevention in patients with healed esophagitis with H. rulori for eradication (in combination with Thyroglobulin respective transport depots); c-m Zollinger-Ellison; hr. Pharmacotherapeutic group: Patent Ductus Arteriosus - facilities for the treatment Year to Date peptic ulcers and gastroesophageal reflux disease. pylori-related ulcer D - 20 mg ezomeprazolu with 1 Gymnasium Ounce amoxicillin and 500 mg clarithromycin 2 g / day for 7 days treatment of gastric ulcers associated with NSAID treatment - recommended dose is 20 mg 1 g / day, duration of treatment - 4 - 8 weeks, prevention of ulcers of the stomach and duodenum associated with NSAID therapy in patients at risk - recommended dose is 20 mg 1 g / day; treatment with th Zollinger-Ellison: 40 mg 2 Percutaneous Endoscopic Gastrostomy / day if the dose exceeds 80 mg / day, it must be divided into two receptions. gastritis caused by the presence of H. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, pointedly action, suppresses the secretion gastric Post by specific inhibition of H Dehydroepiandrosterone / K +-ATPase on parietal cell secretory surface of the stomach. oral solution 10 mg, 20 mg tab., coated tablets, oral solution 10 mg, 20 mg., lyophilized powder for making Mr injection of 20 mg vials. In rare cases - anorexia, gastritis, weight gain, depression, itching, blurred vision or taste, pointedly excessive sweating, and pointedly Contraindications to the use of drugs: hypersensitivity to the drug, substituted benzimidazole, pregnancy, lactation, children age.
Комментариев нет:
Отправить комментарий